-
Aurinia Pharmaceuticals Shareholder Urges Board of Directors to Take Action to Enhance Shareholder Value
07 May 2024 13:28 GMT
… the outstanding shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or … cost-effectiveness. All directors with merger and acquisition-related or research … with a middle or major pharmaceutical company.
Aurinia must undergo significant …
-
ASCs continue to consolidate: The 2023 deals shaping the industry
07 May 2024 21:46 GMT
While there were no notable mega-mergers in the ASC industry in 2023, there was transaction activity by multi-site operators and health systems, according to VMG Health's 2024 Healthcare M&A Report published May 7.
Here are the seven ASC deals to …
-
170,000 Bladder Cancer Vaccine Doses Prepared by ImmunityBio
07 May 2024 21:06 GMT
(Precision Vaccinations News)ImmunityBio, Inc. announced today that the drug substance had been completed and successfully qualified for “fill finish” (filling vials and finishing packaging), sufficient for 170,000 doses of 400mcg ANKTIVA®.
ANKTIVA ( …
-
Spear Names Jim Milton to Its Board
07 May 2024 19:52 GMT
Spear Education, a leading provider of advanced dental education, has announced the appointment of technology executive Jim Milton to its Board of Directors. Mr. Milton is a recognized leader in the education technology space. He was named Higher Education …
-
Globus Medical Reports First Quarter 2024 Results
07 May 2024 20:15 GMT
AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024.
Worldwide net sales were $606.7 million, an increase …
-
Goodness Growth Holdings Announces First Quarter 2024 Results
07 May 2024 20:05 GMT
– Q1 2024 revenue of $21.1 million excluding discontinued operations and NY increased 44.5% year-over-year –
– Submitted a substantial legal filing on May 2nd in the ongoing litigation with Verano – – Company announces launch of Hi*AF and Boundary Waters …
-
How this physician, life science researcher and pharmaceutical company CEO discovered her passion for learning and leadership
04 May 2024 01:39 GMT
… 47;S, a bio pharmaceutical company, gives the keynote … of Ultragenyx and Syros Pharmaceuticals.
Previously, she was … others, overseen numerous successful mergers and acquisitions.”
But she … CEO of Millennium, another pharmaceutical company.
She credits her …
-
Ascendis Pharma Reports First Quarter 2024 Financial Results
02 May 2024 20:01 GMT
… Jan Mikkelsen, Ascendis Pharma’s President and Chief … licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, … Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the … )
(111,701
)
Ascendis Pharma A/S
Consolidated Statements …
-
Valcadia Healthcare Partners Announces Pharma Services M&A Transaction Closing
02 May 2024 18:43 GMT
… closing of its first completed mergers and acquisition engagement, in February … the Health Sciences and Outsourced Pharmaceutical Services industry.
GENERAL VHP BUSINESS …
-
Global Pharma 4.0 Market Growth Strategies by 2024, Business Experts, Industry Trends and Revenue 2031 | Oracle,GE
02 May 2024 11:58 GMT
… partnerships, collaborations, and mergers and acquisitions to increase … report segments the Global Pharma 4.0 market comprehensively … companies.
5⃣ Plan mergers and acquisitions meritoriously by …
Market Challenges
Global Pharma 4.0 Market …